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Molecular methods, established in the 1980s, expanded and delivered tools for the
detection of vestigial quantities of nucleic acids in biological samples. Nucleotide
sequencing of these molecules reveals the identity of the organism it belongs to.
However, the implications of such detection are often misinterpreted as pathogenic,
even in the absence of corroborating clinical evidence. This is particularly significant
in the field of virology where the concepts of commensalism, and other benign or
neutral relationships, are still very new. In this manuscript, we review some fundamental
microbiological concepts including commensalism, mutualism, pathogenicity, and
infection, giving special emphasis to their application in virology, in order to clarify the
difference between detection and infection. We also propose a system for the correct
attribution of terminology in this context.
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INTRODUCTION
For centuries, the diagnosis of an infectious disease was solely based on clinical history and
presentation. The first laboratorial technique used to visualise microbes was microscopy (Gest
et al., 2004). By the 19th century, the relationship between disease and pathogens was established,
triggering a cascade of microbiological lines of research during multiple epidemics such as
smallpox, diphtheria, tuberculosis, cholera, among others. This was pioneered by Robert Koch,
who formulated strict criteria to determine the cause-effect relationship between a microbe and
a disease: (i) The microorganism must be found in diseased but not healthy individuals, (ii) the
microorganism must be cultured from the diseased individual, (iii) the inoculation of a healthy
individual with cultured microorganism must induce disease, and (iv) the microorganism re-
isolated from the inoculated individual may match with the original. This clear set of rules has
since become blurred with increasing understanding of the spectrum of relationships between an
organism and its host, ranging from mutualism to parasitism.
The ambiguity regarding the microbe-host relationship has been further amplified following
the massive explosion of alternative molecular detection methods, such as the polymerase
chain reaction (PCR) (Mullis et al., 1992), which provided the scientific community with new
revolutionary powerful tools to rapidly identify new organisms and genetic diseases. More recently,
Frontiers in Microbiology | www.frontiersin.org 1 May 2021 | Volume 12 | Article 647730
fmicb-12-647730 May 15, 2021 Time: 15:15 # 2
Abade dos Santos et al. Molecular Methods and Virus-Host Interactions
next generation sequencing (NGS) high throughput technology,
which enables rapid sequencing of billions of DNA nucleotides,
has enabled the study of microbiomes through the application
of whole-genome sequencing (WGS) on microbial communities
(metagenomics). The microbiome encompasses all the
microorganisms living in or on any vertebrate animal, and can
be sub-classified into the bacteriome, virome and mycobiome.
The virome is composed of the collection of viruses that
inhabit an organism (Lecuit and Eloit, 2013). In mammals,
this includes viruses that infect the host, endogenous ancient
virus-derived elements inserted in chromosomes, and viruses
that infect members of the host’s microbiome, like the phages that
replicate in bacteria (Virgin, 2014; Cadwell, 2015). Compared to
bacteriomes, human and animal viromes are less well known.
The study of viromes is hindered by several technical limitations,
namely the lack of common markers for viruses, the huge
heterogeneity of the virome components, the difficulties of
working with small samples, the contamination of the samples
by host DNA, the lack of adequate bioinformatic tools for
analysis and the absence of robust, refined and updated databases
(Zou et al., 2016).
Since then, methods such as DNA microarray and genome
sequencing led to the detection of microbes whose pathogenic
potential was unapparent (Young et al., 2015). Some unexpected
viruses have been found in samples from both healthy and
immunosuppressed patients without signs of overt disease
(Sauvage et al., 2011; Kapusinszky et al., 2012). Others have even
been found to have beneficial effects on human and animal health
due to their ability to influence the structure and function of
bacterial communities through prokaryotic viruses (Sandaa et al.,
2018). The ability to detect a tremendous variety of viruses with
unclear pathogenic potential (Table 1) has re-emphasised the
importance of an accurate description of the symbiosis.
Our perception of the role of viruses has shifted from solely
sources of acute, persistent, or latent infections to commensal
or even mutualistic organisms. The intricacy of virus-host
relationships is reflected in the human genome composition, of
which 5–8% is constituted by endogenous retroviruses (ERVs)
(Nelson et al., 2004).
Today, molecular biology is an invaluable tool for diagnosis
and research. However, the molecular detection of a potential
pathogen in an animal or human can be easily misinterpreted.
In the absence of corroborating clinical evidence, molecular
detection often results in the assumption of an infection by
default. This has become increasingly relevant in the field of
virology, since the discovery of commensal and mutualistic
viruses. The isolation and identification of a potential pathogen
must be evaluated alongside the context of the microbial
community to which it belongs to and the clinical evidence to
suggest its interaction with the host.
In this manuscript, we review some fundamental
microbiological concepts and explore how continuous
discoveries in the field of microbiology demand some degree of
re-framing of these concepts. We also discuss the strengths and
weaknesses of several molecular diagnostic methods, exploring
the differing implications of positive results. Finally, we propose a
system for the correct attribution of terminology in this context.
TABLE 1 | Examples of commensal viruses.
Family Evidence of colonisation
Anelloviridae They are ubiquitous within the human species and have not
yet been causally linked to any disease (Hino and Miyata,
2007; De Villiers and Zur Hausen, 2009). These viruses have
been found in various organs, tissues and cell types (Tajiri
et al., 2001; Thom et al., 2003), including plasma where they
can cause persistent viraemia in 70% of worldwide




Three predominant families of viruses are found to colonise
the human skin. Similarly to the skin microbiome, the skin
human virome is composed of both resident and transient
viruses (Lecuit and Eloit, 2013). High seropositivity (90%) to
at least one human papilloma virus type has been reported in
the human skin (Antonsson, 2012). Merkel cell polyomavirus,
human polyomavirus 6, 7, and 9, are considered skin-tropic
polyomaviruses existing chronically in healthy individuals
(Feltkamp et al., 2013). Seropositivity of capsid protein VP1,
a major structural component of the polyomavirus, can be
detected in nearly 100% of the human population (Ott et al.,
2000). Cyclovirus and other Circoviridae members are found
in skin surface of both human and animals with cross-species
transmission appearing possible (Li et al., 2011)
Picornaviridae In the gastrointestinal tract, persistent or intermittent
shedding of enteric viruses from healthy people is well
established Human enterovirus Witsø et al., 2006 and
parechovirus Olijve et al., 2018 are excreted by a large
fraction of children under the age of five without any evidence
of association with disease (Witsø et al., 2006; Olijve et al.,
2018). Additionally, human enterovirus type 3 and 4 have the
pig as reservoir Smith and Purdy, 2013
Anelloviridae Kapusinszky et al. (2012) observed nearly constant shedding
of anelloviruses including torque teno viruses Torque teno
virus viraemia can be identified in nearly all individuals
THE SPECTRUM OF HOST-ORGANISM
RELATIONSHIPS
The initial definitions underlying most of the concepts of
microbiology were largely pathogen-centred. Later, the
recognition that many microbial agents may interact with
certain hosts without causing disease led to the establishment of
new terminology to describe the distinct situations where this
might happen. Social relationships between organisms can be
very complex. The same organism can engage in different types
of biological relationships with other organisms or hosts and
follow co-evolutionary paths.
Below, we describe some of the most common symbiotic
relationships between microorganisms and their hosts in which
at least one of the partners involved in the interaction benefits
from this close relationship.
Symbiotic relationships between animals and microorganisms
are common and well-known, although terms like
commensalism, mutualism and parasitism, referring to different
types of symbiotic relationships are sometimes misunderstood.
In virology, these terms are largely underused.
Commensalism
Commensalism describes the relationship between two
organisms where one partner benefits whilst the other remains
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unaffected. Mutualism describes a relationship in which both
partners take advantage (win-win relationship) and the term
“parasitism” refers to the case where one partner takes advantage
over the other (win-lose relationship). This is often applied when
the invading organisms produce harm to the host – infection
(Fierer et al., 2017).
One could argue that viruses are by nature intracellular
parasites, given that they rely on the high-jacking of cellular
processes to replicate. In fact, it was believed that the normal
cellular function would be disturbed in this process, leading
inevitably to emergence of disease (Griffiths, 1999). As such it
is unsurprising that the term “commensal” was never used in
the same way in virology (Mims et al., 1998). However, Griffiths
(1999) proposed the concept of “commensal viruses,” suggesting
they might remain within their host in a low replicative phase
without therefore causing virus-induced cytolysis. For example,
whilst an organism can be part of the natural and healthy
microbiota without triggering any infectious disease, it can still
pose the threat of pathogenicity. Threat as it can increase in
number in the microbial community and lead to the onset of
an infection. Because symbiotic relationships are dynamic and
evolve over time, the imbalance of the bacterial diversity and
load (dysbiosis) can become detrimental to the host (Zhang
et al., 2015), and may promote opportunistic infections. Such
is the case in the onset of pseudomembranous colitis following
antibiotic therapeutic protocols, due to the overgrowth of the
bacterial opportunistic pathogen Clostridium difficile in the
human gut (David et al., 2019; Nogueira et al., 2019). Similarly,
the overgrowth of the commensal yeast Candida albicans can
result in oral thrush and oesophagitis (Deepa et al., 2014).
Mutualism
Microbiota that reside in the epithelial tissue that is exposed
to the external environment in the respiratory, gastrointestinal
and vaginal tracts as well as in the skin since birth are often
called commensal (Tlaskalová-hogenová et al., 2004), suggesting
that neither it, nor its host, benefit or suffer from its presence.
However, extensive research on the effect of microbiota on
human and animal health has highlighted the presence of many
symbiotic relationships between microorganisms and the host,
generally beneficial to the host, and therefore better described as a
type of mutualistic relationship (Macpherson and Mccoy, 2014).
The bacteria composing the human gut microbiota supply
vitamins, aid in digestion of carbohydrates, maintain the integrity
of mucosal barrier, and prevent overgrowth and invasion of
pathogenic bacteria (Zhang et al., 2015).
Microbiota imbalances have therefore been linked to
many human diseases including inflammatory bowel diseases,
cardiovascular disease, obesity, and type 2 diabetes (Malinen
et al., 2005; Frank et al., 2007; Turnbaugh et al., 2009; Larsen
et al., 2010; Gerritsen et al., 2011; Kerckhoffs et al., 2011).
Mutualistic relationships between viruses and their hosts
have also been revealed. Some authors have suggested that
highly prevalent viruses, such as herpesviruses, may actually
play a protective role against bacterial infection by boosting
innate immunity (Dickinson, 2018). Some mouse herpesviruses,
highly similar to the human Epstein Barr virus (EBV) and
cytomegalovirus (CMV), activate the innate immune response
and protect mice against bacteria (Barton et al., 2007). The
γ-herpesvirus 68 (γHV68), for example, was found to protect
against infection by Listeria monocytogenes and Yersinia pestis
by sustaining IFN-γ production and macrophage activation
(Barton et al., 2007). The murine norovirus can replace many
of the benefits provided by commensal bacteria in the intestine
(Kernbauer et al., 2014), and chronically it can lead to low
expression of Atg16L1, an autophagy gene with allelic variants
that predisposes to Crohn’s disease. The surprising finding that
gyroviruses encode a protein that is specifically cytotoxic to
cancer cells, raises the possibility that some viral infections can
be beneficial in controlling the development of tumour cells (Los
et al., 2009), whilst others are directly causative of certain kinds
of cancer, such as Burkitt’s lymphoma and cervical cancer.
PATHOGENICITY, VIRULENCE, AND
INFECTION
A pathogen is a microorganism that can cause damage to its
host. Pathogenicity results from the expression of virulent factors,
proteins which are essential for the invasion and colonisation
of the host, evasion of its immune system and nutrient uptake
at its expense. Infection is the damage inflicted on the host
during this process.
Casadevall and Pirofski (2000) highlighted that a coloniser
organism can cause varying degrees of damage to its host, from
none to substantial. The latter effect induces host responses that
might be successful in eliminating the microbe or might be
unsuccessful, consequently progressing to chronic infection. For
those organisms that, once having colonised the host, induce
no damage, its state is indistinguishable from “commensalism”
(Casadevall and Pirofski, 1999).
SARS-CoV-2, is an example of a pathogen that induces a
range of symptoms. Although a significant proportion of people
infected with this virus do not display any symptoms (Yanes-
Lane et al., 2020), detection of the virus in these individuals is
always referred to as an infection, albeit asymptomatic, given the
clear association between the pathogen and respiratory disease it
is capable of causing. These asymptomatic infections differ from
commensal colonisation due to the complete elimination of the
offending organism by the immune system.
In 1999, Casadevall and Pirofski revised the term “pathogen”
to mean a microbe capable of causing damage to its host, to
highlight what they believed was the most relevant outcome of
the host-pathogen interaction (Casadevall and Pirofski, 2000).
Injury can result from either direct microbial action or the
host immune response, or often both, can usually be identified
through a combination of symptomatology, clinical examination
and histology. However, damage being inflicted at a cellular
level may escape detection by these methods. For example, high-
risk human papillomavirus (HPV) types, responsible for the
vast majority of cervical cancers, inactivate the essential tumour
suppressor genes pRb and p53 in host cells in order to induce
in them a perpetual replicative state, necessary for optimal viral
replication (Buitrago-pérez et al., 2009). Silencing of tumour
Frontiers in Microbiology | www.frontiersin.org 3 May 2021 | Volume 12 | Article 647730
fmicb-12-647730 May 15, 2021 Time: 15:15 # 4
Abade dos Santos et al. Molecular Methods and Virus-Host Interactions
suppressor genes in cervical cells does not immediate cause overt
injury that is clinically or histologically identifiable. In fact, pre-
cancerous dysplastic changes, can take a number of years to
develop (Burd and Burd, 2003; Castle and Fetterman, 2009).
Nonetheless, lack of evidence of damage does not indicate the
offending organism is not a pathogen, when there is substantial
reliable historical scientific evidence to the contrary.
Organisms can be described in terms of virulence and
pathogenicity, which have been defined in various ways
throughout the years, but overall describe the features or
characteristics that enable an organism to cause disease and
the degree or speed at which a pathogen can cause disease,
respectively. Some concepts were recently revised by Casadevall
and Pirofski (1999). These authors critically reviewed the
origin and historical definitions of terms namely infection,
commensalism, colonisation, persistence, infection, and disease
and updated them in order to recognise current knowledge.
According to Lwoff (1957), “infection” is the introduction of a
foreign entity that is capable of multiplying to produce additional
infectious entities into an organism, regardless of whether this
results in a disease. This definition encompasses the concept of
subclinical or unapparent infections, which cause no signs or
symptoms (Mahy, 2009).
Arguably, there are pitfalls to all definitions. Prions, infective
proteins that can cause often devastating disease, might not
technically be classified as microorganisms, and yet their
pathogenicity is undeniable. This is also the case with infectious
nucleic acid and infectious viral particles, which contain partial
or complete viral genome. Some microorganisms pertaining
to the healthy microbiota, although beneficial to their hosts
much of the time, have the potential to cause disease though
opportunistic infection. We rely on our microbiome to perform
many human physiological functions, such as vitamin synthesis.
Should these organisms be thought of as pathogens, as per
Casadevall and Pirofski (1999), because they have the potential
to cause damage? This seems to overlook their potential for
beneficial effects. We do not agree with their revised definition
of “infection,” we would argue that “acquisition of a microbe
by host” should preferably be defined instead as “colonisation”
when the impact on the host is unknown. After this process
of “acquisition,” the pathophysiological sequence, it is often
possible to predict and dependent on the pathotype – a group of
organisms with same pathogenicity on a host. Only with evidence
of pathogenesis caused by the colonisation of this organism, in an
acute, chronic or intermittent manner, can the process be labelled
an “infection.” This distinction better reflects the implications of
this microbiological process in clinical practice.
INEQUALITY OF DIAGNOSTIC TESTS:
DETECTION VERSUS INFECTION
There is a growing range of widely available diagnostic methods
capable of detecting an organism or potential pathogen.
Culture-based methods provide evidence of viable infectious
pathogens in the sample by demonstrating the growth of
organisms in vitro. This is not only applicable to the growth
of bacteria in culture media, but also to the growth of
viruses and intracellular bacteria in susceptible eukaryotic
cell lines. Although the growth of bacteria can be observed
with the naked eye or simple light microscopy, growth of
intracellular bacteria and viruses can be confirmed through
staining techniques or identification of specific virus-induced
cytopathic effects. Electron microscopy (EM) can be used to
identify both mature and immature forms of viral particles
within a cell. The simultaneous presence of both forms
indicates active viral replication. However, it has a much lower
sensitivity than molecular methods and requires specialised
technicians and equipment.
Antigen tests detect certain proteins of a specific organism
through immunoassays. They are quick and achieve a high
specificity by targetting proteins or specific epitopes that are
singular to the pathogen being detected. However, antigen
tests can have low sensitivities, and therefore a higher rate of
false negative results, when compared to PCR. Rapid influenza
diagnostic tests (RIDTs), for example, which detect influenza
virus nucleoproteins, only achieve a sensitivity of around 50–
80% (CDC, 2020b). COVID-19 lateral flow rapid antigen tests
also vary in sensitivity from 79%, when performed by laboratory
scientists, to 58%, when performed by self-trained members of
the public (Mahase, 2020). Rapid antigen tests for pathogens
like group A beta-haemolytic streptococci and Hepatitis B virus,
on the other hand, have substantially higher sensitivities of 90%
and above (Joslyn et al., 1995). The sensitivity of these tests
is dependent on factors such as timing of sample collection,
collection technique and viral load (Tanei et al., 2014).
Importantly, a viable virus is not required for detection of
an antigen. In infections like COVID-19 where viral shedding
continues beyond the resolution of infection, meaning there
is the presence of virus particles but no actual viable virus, a
positive antigen test cannot distinguish between active infection
with transmission potential and resolved infection without
transmission potential (Cevik et al., 2021). Antigen detection
should, therefore, be interpreted as current or recent infection
and should not infer infectiousness.
Antibodies are produced by the humoural immune system
in response to the detection of an antigen and can arise from
either natural infection or vaccination. A positive antibody test
thus indicates that there has been, at some point, an exposure
to the organism.
There are several ways to distinguish between active and past
infection. Detection of IgM antibodies, which are produced as the
first response to a new infection but are only short-term and start
dropping a few weeks after infection, is likely to indicate a current
or recent infection.
IgG antibodies, on the other hand, are produced later, in the
course of the infection, and can remain in the bloodstream for
months to years. Because the lag time between initial infection
and antibody production, timing of this diagnostic test is crucial
to avoid false negative results.
The detection of specific class of antibodies against non-
structural viral proteins is indicative of active viral replication
and is therefore also a useful tool to detect ongoing infection.
Unlike non-structural protein, which are present in much larger
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FIGURE 1 | Schematic representation of scientific process to classification of virus-host interaction.
amounts, the structural proteins are fewer and less immunogenic.
Their antibodies are thus short-lived and consequently un-
detectable soon after the resolution of infection.
They have also been used in Differentiate Infected from
Vaccinated Animals (DIVA) tests, given vaccines (with the
exception of live and attenuated vaccines) do not result in the
production of antibodies against non-structural proteins. This is
the case with Hepatitis B. Surface antibodies can be produced in
response to both active infection and as a result of vaccination,
whereas core (non-structural) antibodies are only produced
following natural infection.
Molecular based detection methods have some unquestionable
advantages compared to the methods mentioned above,
including their greater sensitivity, specificity and ability to be
automated. However, the component that is being detected,
whether that be genomic components or messenger RNA is
paramount to the interpretation of a positive result.
Other group of molecular diagnostic tests detect genetic
material that is specific an organism. The detection of mature
messenger RNA provides evidence of active infection, as it
implies gene expression, contrary to positivity by standard PCR,
where detection may also represent the presence of nucleic acids
from non-viable and therefore non-infectious organisms. The
detection of mRNA can, therefore, help distinguish between viral
latency and active replication (Lecuit and Eloit, 2013).
Although highly sensitive and specific, PCR test results are
not always clear-cut with other interpretation issues such as the
clinical significance of weaker signals, which represent a low copy
number of a particular pathogen (Louie et al., 2000).
In situ hybridisation (ISH) detects viral genome in tissues
or cells, by localisation of specific unique or repeated DNA
and RNA sequences using complementary labelled probes. ISH
demonstrates specific nucleic acid sequences in their cellular
environment. As such, it can provide information regarding the
level and place of mRNA expression, demonstrating the presence
of newly synthesised viral DNA or RNA within cells, hence
confirming the pathogens viability.
Some examples of diverse interpretations of molecular results
have been provided over the years in both the bacteriology
and virology fields. In 2019 the Centre for Disease Control
and Prevention (CDC) alerted to the fact that although rapid
molecular assays including PCR and other alternative nucleic
acid amplification methods can detect viral RNA in respiratory
specimens with high sensitivity and specificity, this result does
not necessarily indicate detection of a viable virus or on-
going influenza viral replication (CDC, 2019). Similarly, the
detection of cytomegalovirus DNA from a patient’s serum
cannot distinguish between active disease or latent infection
(Ljungman et al., 2017), which are distinct situations from a
clinical standpoint. Therefore, the use of sensitive laboratory
techniques to test for the presence of novel viruses must be
supported by additional clinical evidence to convincingly indicate
that the detected virus was the cause of the observed disease
(Griffiths, 1999).
The nuances of molecular biology result interpretation is a
significant topic of discussion in the context of the recent global
outbreak of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) (Suri et al., 2020). Multiple studies have described
a positive RT-PCR result several days after recovery (Lan et al.,
2020; Young et al., 2020). Other cases have reported positive RT-
PCR results following several consecutive negative results. The
clinical and infection-control implications of this are unclear.
However, the general consensus is that viral RNA detection
does not necessarily indicate the presence of active infection or
transmissible viable viral particles (CDC, 2020a). In fact, RT-
PCR detects RNA, not an infectious agent, limiting the ability to
determine the infectiousness of patients or animals with a positive
PCR (Bullard et al., 2020). It has been suggested that quantifying
viral loads may help to clarify the likely clinical picture. One
study correlated the success of viral isolates with viral loads,
Frontiers in Microbiology | www.frontiersin.org 5 May 2021 | Volume 12 | Article 647730
fmicb-12-647730 May 15, 2021 Time: 15:15 # 6
Abade dos Santos et al. Molecular Methods and Virus-Host Interactions
and found that samples containing <106 copies per ml never
yielded an isolate. Thus it concluded that despite the detection
of viral loads long after symptom resolution there would be little
residual risk of infection (Wölfel et al., 2020). Given the general
ambiguity around infective potential of recovered patients, future
focus on detection of mRNA throughout the course of the disease,
rather than RNA, might produce more elucidating results. This
COVID-19 pandemic has highlighted the importance of correct
interpretation of molecular biology test results given its potential
to influence global guidance on appropriate time of patient
discharge and isolation length.
CONCLUSION
Molecular biology, biotechnology, genomics, and bioinformatics
were the basis for one of the most important revolutions in recent
microbiology, providing a boom of different conceptual methods
that quickly replaced most of the classic, time-consuming,
and laborious laboratorial techniques used for the diagnosis of
microbiological diseases. This revolution represented a change
of focus from the agent itself to the simple identification of
nucleic acids. However, contrary to the method of culture and
isolation in cell lines, the detection of nucleic acid does not
necessarily indicate the presence of viable organisms capable of
replication and infection, given viral particles can persist even
after resolution of infection. Other methods aimed at detecting
messenger RNA or non-structural proteins on the other hand can
reliably indicate an active infection.
Molecular biology is not only enabling the identification
of new viruses but also the genotyping and viral load
quantification of these organisms. However, virology has
lagged in the exploration of the different types of virus-
host relationships. For viruses, whose pathogenic virulence
is recognised, the characterisation of virus-host relationships
is simple. Nonetheless, a growing number of non-pathogenic
viruses establish states of commensalism or mutualism with their
hosts. At times, key features of these complex microbiological
states and processes overlap, impairing recognition and
classification. This issue is further exacerbated by the nature of
most investigations, which are not longitudinal and therefore
cannot capture such dynamics.
Thus, we emphasise the importance of combining
physiopathological evidence to the molecular data when
describing the novel presence of a microorganism in a host.
Where this is not possible, we suggest the use of more
conservative language which avoids charged terms such as
“infection” and “pathogen.” To aid the appropriate use of what
should be standardised terminology, we propose a rationale to
characterise microbe-host relationships (Figure 1).
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